Holy Stone Healthcare Co., Ltd. (TPEX:4194)
7.05
-0.08 (-1.12%)
Jan 22, 2026, 1:57 PM CST
Holy Stone Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| 47.51 | 118.77 | 236.89 | 270.24 | 217.08 | 221.6 | Upgrade | |
Revenue Growth (YoY) | -78.63% | -49.86% | -12.34% | 24.49% | -2.04% | 8.54% | Upgrade |
Cost of Revenue | 37.79 | 85.91 | 137.51 | 146.97 | 115.26 | 123.12 | Upgrade |
Gross Profit | 9.72 | 32.86 | 99.38 | 123.28 | 101.83 | 98.48 | Upgrade |
Selling, General & Admin | 31.27 | 48.51 | 89.42 | 93.87 | 84.04 | 81.42 | Upgrade |
Research & Development | 152.85 | 174.16 | 298.26 | 179.38 | 187.6 | 148.29 | Upgrade |
Operating Expenses | 184.09 | 222.68 | 387.99 | 272.23 | 277.29 | 227.27 | Upgrade |
Operating Income | -174.37 | -189.82 | -288.6 | -148.95 | -175.46 | -128.8 | Upgrade |
Interest Expense | -0.61 | -0.64 | -0.63 | -0.43 | -0.51 | -0.49 | Upgrade |
Interest & Investment Income | 3.42 | 3.31 | 2.51 | 2.51 | 0.84 | 2.13 | Upgrade |
Currency Exchange Gain (Loss) | -0.31 | 0.42 | 1.27 | -2.27 | -2.96 | -0.85 | Upgrade |
Other Non Operating Income (Expenses) | 32.32 | 3.26 | 1.03 | 2.71 | 1.95 | 1.88 | Upgrade |
EBT Excluding Unusual Items | -139.54 | -183.47 | -284.42 | -146.44 | -176.14 | -126.12 | Upgrade |
Pretax Income | -139.54 | -183.47 | -284.42 | -146.44 | -176.14 | -126.12 | Upgrade |
Income Tax Expense | 0.05 | 0.03 | 4.95 | 6.51 | 5.17 | 2.64 | Upgrade |
Earnings From Continuing Operations | -139.59 | -183.49 | -289.37 | -152.94 | -181.31 | -128.76 | Upgrade |
Net Income | -139.59 | -183.49 | -289.37 | -152.94 | -181.31 | -128.76 | Upgrade |
Net Income to Common | -139.59 | -183.49 | -289.37 | -152.94 | -181.31 | -128.76 | Upgrade |
Shares Outstanding (Basic) | 146 | 142 | 137 | 119 | 109 | 109 | Upgrade |
Shares Outstanding (Diluted) | 146 | 142 | 137 | 119 | 109 | 109 | Upgrade |
Shares Change (YoY) | 1.47% | 3.76% | 14.79% | 9.39% | - | 30.64% | Upgrade |
EPS (Basic) | -0.96 | -1.29 | -2.12 | -1.29 | -1.67 | -1.18 | Upgrade |
EPS (Diluted) | -0.96 | -1.29 | -2.12 | -1.29 | -1.67 | -1.18 | Upgrade |
Free Cash Flow | -93.23 | -144.76 | -280.82 | -148.09 | -142.16 | -101.82 | Upgrade |
Free Cash Flow Per Share | -0.64 | -1.02 | -2.06 | -1.24 | -1.31 | -0.94 | Upgrade |
Gross Margin | 20.45% | 27.67% | 41.95% | 45.62% | 46.91% | 44.44% | Upgrade |
Operating Margin | -367.05% | -159.83% | -121.83% | -55.12% | -80.83% | -58.12% | Upgrade |
Profit Margin | -293.84% | -154.50% | -122.15% | -56.59% | -83.52% | -58.10% | Upgrade |
Free Cash Flow Margin | -196.25% | -121.88% | -118.55% | -54.80% | -65.48% | -45.95% | Upgrade |
EBITDA | -167.98 | -183.59 | -280.09 | -140.64 | -166.44 | -119 | Upgrade |
EBITDA Margin | - | -154.59% | -118.24% | -52.04% | -76.67% | -53.70% | Upgrade |
D&A For EBITDA | 6.39 | 6.23 | 8.51 | 8.31 | 9.02 | 9.8 | Upgrade |
EBIT | -174.37 | -189.82 | -288.6 | -148.95 | -175.46 | -128.8 | Upgrade |
EBIT Margin | - | -159.83% | -121.83% | -55.12% | -80.83% | -58.12% | Upgrade |
Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.